Table 2.
Groups | n | Anti-PLA2R antibody (RU/mL) |
---|---|---|
PMN | 64 | 226.62±366.49 |
SMN | 40 | 9.09±9.75a |
non-MN | 60 | 5.11±3.80a |
F | 18.004 | |
P | 0 |
Notes: SMN and non-MN compared with PMN,
P<0.05. The serum anti-PLA2R antibody level in the PMN group was significantly higher than that in the SMN group and non-MN group.
Abbreviations: MN, membranous nephropathy; PMN, primary membranous nephropathy; SMN, secondary membranous nephropathy.